Opportunity Information: Apply for HRSA 15 030

  • The Health Resources and Services Administration in the health sector is offering a public funding opportunity titled "Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Dissemination and Evaluation Center" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.928 Special Projects of National Significance.
  • This funding opportunity was created on May 7, 2015 and posted on Apr 27, 2015.
  • Applicants must submit their applications by Jun 23, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Public and nonprofit private entities eligible for funding under Parts A D of Title XXVI of the Public Health Service (PHS) Act as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009, including academic institutions, non profit organizations and faith based organizations. Additionally, the District of Columbia, the Commonwealth of Puerto Rico, the Territories of the Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands, and Indian Tribes or tribal organizations are also eligible to apply for these funds.
Apply for HRSA 15 030

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Health Resources and Services Administration (HRSA) announced this fiscal year 2015 funding opportunity to support one national organization to serve as the Dissemination and Evaluation Center (DEC) for a new Ryan White HIV/AIDS Program Special Projects of National Significance (SPNS) initiative focused on improving outcomes along the HIV Care Continuum, with a clear emphasis on increasing viral suppression. The DEC is intended to act as both a dissemination hub and an evaluator, meaning it is responsible not only for packaging and spreading proven intervention approaches but also for rigorously assessing how well those approaches work when implemented in real-world HIV care settings. Funding is provided as a cooperative agreement for up to five years, and the project is designed to help HIV care organizations replicate evidence-informed interventions quickly and effectively by offering practical implementation tools, technical guidance, and evaluation-driven lessons learned.

A major feature of the program is that the DEC must adapt and prepare four interventions so they are implementation-ready for today’s healthcare environment. These interventions are drawn from earlier SPNS and related initiatives: Enhancing Linkages for Those Newly Released from Jails (the SPNS Jails Initiative, 2007-2012), Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care (the Buprenorphine Initiative, 2004-2009), Targeted HIV Outreach and Intervention Model Development and Evaluation for Underserved HIV-Positive Populations Not in Care (the SPNS Outreach Initiative, 2001-2006), and the Secretary’s Minority AIDS Initiative Fund Retention and Re-Engagement Project (also known as the Peer Re-Engagement Project, 2011-2014). The intent is to take what was learned in those earlier projects and translate it into practical, current, step-by-step interventions that Ryan White-funded provider organizations can integrate into their ongoing change management and quality improvement efforts.

During Year 1, the DEC’s work is front-loaded with product development and planning. The center is expected to produce four adapted interventions in a form that is ready for adoption by clinical sites. It must also create web-based dissemination materials for each intervention, explaining in plain operational terms what the intervention consists of, the theory or rationale behind it, the specific activities involved, staffing models, training requirements, and any available cost information. The funding announcement expects these materials to be grounded in evidence, so the DEC must also compile and reference existing publications, evaluation reports, and journal articles that support the intervention’s evidence-informed status. Each intervention is required to have its own dedicated webpage on the existing TARGET Center website (Technical Assistance Resources, Guidance, Education and Training), essentially turning the TARGET platform into the primary public-facing repository where other HIV service organizations can learn about and replicate the approaches.

Year 1 is also when the DEC designs the multi-site evaluation plan that will be carried out later. This evaluation is expected to look at fidelity (whether sites implement the intervention as intended), effectiveness (whether implementation leads to improved outcomes), and costs (what it takes to implement and sustain the intervention). The evaluation is structured around implementation by up to 12 performance sites, which are selected and funded through a separate mechanism. That separation is important: the DEC does not fund the clinical sites directly under this opportunity, but it must coordinate closely with the broader initiative so that evaluation data collection and reporting can happen consistently across sites.

The DEC is not operating alone. The initiative includes an Implementation Technical Assistance Center (ITAC), funded through a different funding opportunity announcement (HRSA 15-130), and the DEC must collaborate closely with that ITAC. In practice, that means the DEC leads the development of intervention-specific implementation plans while partnering with the ITAC to translate those plans into hands-on technical assistance agendas for performance sites. Those agendas include structured site visit protocols developed by the ITAC with input from the DEC. This division of labor continues in Years 2 through 4: the ITAC focuses on implementation technical assistance, while the DEC focuses on evaluation technical assistance and evaluation operations, including ensuring the sites collect the right outcome, process, and cost data in a usable and comparable way.

In Years 2 through 4, the DEC runs the multi-site evaluation while the selected performance sites implement one of the adapted interventions in their clinical settings. The DEC’s responsibilities in this period include coordinating data collection, providing guidance on evaluation methods and reporting, and analyzing how implementation plays out across different real-world environments. The expectation is that the findings will go beyond simple outcome reporting and will capture the practical barriers and facilitators that affect replication, including workflow impacts, staffing realities, training burdens, and cost considerations. As results emerge, the DEC is expected to revise and strengthen the web-based intervention materials already posted on the TARGET Center website so that future adopters benefit from the newest lessons and refinements rather than relying on static guidance.

Dissemination is treated as equally important as evaluation in this announcement. The DEC must actively publish and spread findings from the initiative, including best practices, lessons learned, and cost analyses, with the explicit goal of accelerating replication by other HIV care organizations. In other words, the DEC is meant to function like a national translation engine, taking interventions that have evidence behind them, testing how they perform when scaled into routine practice across multiple sites, and then converting those insights into practical tools that make broader rollout faster and more reliable.

The opportunity was posted under Funding Opportunity Number HRSA 15-030, within CFDA 93.928 (Special Projects of National Significance). HRSA anticipated making one award, with an estimated total funding amount of $500,000, and there is no cost sharing or matching requirement listed. Eligible applicants include public entities and nonprofit private entities that are eligible for funding under Parts A through D of Title XXVI of the Public Health Service Act (as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009), which can include academic institutions, nonprofit organizations, and faith-based organizations. The announcement also allows applications from certain U.S. territories and associated jurisdictions and from Indian Tribes or tribal organizations. The closing date was listed as June 23, 2015 (with an original closing date of June 22, 2015), and HRSA provided a program contact for applicants needing assistance.

At a practical level, HRSA is signaling that the strongest DEC applicants should already have demonstrated capacity to manage national, multi-site evaluations and to translate complex interventions into clear, user-friendly implementation packages. The emphasis on viral suppression and care continuum outcomes suggests HRSA is looking for evaluation designs that can connect implementation quality to measurable clinical and engagement outcomes, while also producing realistic cost information and operational guidance that Ryan White provider organizations can use without having to reinvent the model.

Funding Opportunity FAQs (HRSA 15-030: Dissemination and Evaluation Center for SPNS HIV Care Continuum Initiative)

What is this funding opportunity about?

This HRSA funding opportunity (FY 2015) supports one national organization to serve as the Dissemination and Evaluation Center (DEC) for a new Ryan White HIV/AIDS Program Special Projects of National Significance (SPNS) initiative focused on improving outcomes along the HIV Care Continuum, with a clear emphasis on increasing viral suppression.

What is the DEC expected to do?

The DEC is expected to function as both a dissemination hub and an evaluator. That includes packaging and spreading proven, evidence-informed intervention approaches and rigorously assessing how well those approaches work when implemented in real-world HIV care settings.

How many awards did HRSA anticipate making?

HRSA anticipated making one award.

What is the estimated total funding amount?

The estimated total funding amount listed is $500,000.

What type of funding mechanism is used?

Funding is provided as a cooperative agreement.

How long is the project period?

The cooperative agreement can support the project for up to five years.

Is cost sharing or matching required?

No cost sharing or matching requirement is listed for this opportunity.

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number is HRSA 15-030.

What CFDA program is this associated with?

This opportunity is listed under CFDA 93.928 (Special Projects of National Significance).

Who is eligible to apply?

Eligible applicants include public entities and nonprofit private entities that are eligible for funding under Parts A through D of Title XXVI of the Public Health Service Act (as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009). The description notes this can include academic institutions, nonprofit organizations, and faith-based organizations.

Are tribal entities eligible to apply?

Yes. The announcement allows applications from Indian Tribes or tribal organizations.

Are U.S. territories eligible to apply?

Yes. The announcement allows applications from certain U.S. territories and associated jurisdictions.

What was the application closing date?

The closing date was listed as June 23, 2015 (with an original closing date of June 22, 2015).

What is the main program goal?

The initiative focuses on improving outcomes along the HIV Care Continuum, with a clear emphasis on increasing viral suppression.

What interventions must the DEC adapt and prepare?

The DEC must adapt and prepare four interventions so they are implementation-ready for today’s healthcare environment. The interventions are drawn from earlier SPNS and related initiatives:

  • Enhancing Linkages for Those Newly Released from Jails (SPNS Jails Initiative, 2007-2012)
  • Integrating Buprenorphine Opioid Abuse Treatment in HIV Primary Care (Buprenorphine Initiative, 2004-2009)
  • Targeted HIV Outreach and Intervention Model Development and Evaluation for Underserved HIV-Positive Populations Not in Care (SPNS Outreach Initiative, 2001-2006)
  • Secretary’s Minority AIDS Initiative Fund Retention and Re-Engagement Project (Peer Re-Engagement Project, 2011-2014)

What does "implementation-ready" mean in this announcement?

Based on the description, "implementation-ready" means the DEC translates what was learned from earlier projects into practical, current, step-by-step interventions that Ryan White-funded provider organizations can integrate into ongoing change management and quality improvement efforts.

What are the DEC’s main deliverables in Year 1?

Year 1 is described as front-loaded with product development and planning. The DEC is expected to:

  • Produce four adapted interventions in a form ready for adoption by clinical sites
  • Create web-based dissemination materials for each intervention
  • Compile and reference supporting evidence (publications, evaluation reports, journal articles)
  • Create a dedicated webpage for each intervention on the existing TARGET Center website
  • Design the multi-site evaluation plan to be carried out later

What must the web-based dissemination materials include?

The announcement expects the web-based materials to explain, in plain operational terms:

  • What the intervention consists of
  • The theory or rationale behind it
  • The specific activities involved
  • Staffing models
  • Training requirements
  • Any available cost information
  • References to evidence supporting the intervention (publications, evaluation reports, journal articles)

Where must the intervention materials be posted?

Each intervention is required to have its own dedicated webpage on the existing TARGET Center website (Technical Assistance Resources, Guidance, Education and Training). The TARGET platform is intended to serve as the primary public-facing repository for learning and replication.

What is the evaluation expected to measure?

The evaluation is expected to assess:

  • Fidelity (whether sites implement the intervention as intended)
  • Effectiveness (whether implementation leads to improved outcomes)
  • Costs (what it takes to implement and sustain the intervention)

How many clinical performance sites are involved in the multi-site evaluation?

The evaluation is structured around implementation by up to 12 performance sites.

Does the DEC directly fund the performance sites?

No. The performance sites are selected and funded through a separate mechanism. Under this opportunity, the DEC does not fund the clinical sites directly, but it must coordinate with the broader initiative so evaluation data collection and reporting are consistent across sites.

What other center or partner is part of this initiative?

The initiative includes an Implementation Technical Assistance Center (ITAC), funded through a different funding opportunity announcement (HRSA 15-130). The DEC is expected to collaborate closely with the ITAC.

How are responsibilities divided between the DEC and the ITAC?

As described:

  • The DEC leads development of intervention-specific implementation plans and focuses on evaluation technical assistance and evaluation operations.
  • The ITAC focuses on implementation technical assistance, including structured site visit protocols developed by the ITAC with input from the DEC.

What does the DEC do in Years 2 through 4?

In Years 2 through 4, the DEC runs the multi-site evaluation while selected performance sites implement one of the adapted interventions. The DEC’s responsibilities include coordinating data collection, providing guidance on evaluation methods and reporting, and analyzing implementation across different real-world environments.

What kinds of real-world implementation factors is the DEC expected to capture?

The findings are expected to include practical barriers and facilitators affecting replication, including workflow impacts, staffing realities, training burdens, and cost considerations, not just simple outcome reporting.

Are the intervention materials expected to be updated over time?

Yes. As results emerge, the DEC is expected to revise and strengthen the web-based intervention materials on the TARGET Center website so future adopters can use updated lessons and refinements rather than static guidance.

How important is dissemination compared to evaluation in this announcement?

Dissemination is treated as equally important as evaluation. The DEC must actively publish and spread findings from the initiative, including best practices, lessons learned, and cost analyses, with the goal of accelerating replication by other HIV care organizations.

What is the practical intent behind this DEC role?

The DEC is intended to act like a national translation engine: take interventions with evidence behind them, test how they perform when scaled into routine practice across multiple sites, and convert those insights into practical tools that make broader rollout faster and more reliable.

What does HRSA signal it wants from strong applicants?

HRSA signals that strong DEC applicants should already have demonstrated capacity to manage national, multi-site evaluations and translate complex interventions into clear, user-friendly implementation packages. The emphasis on viral suppression and HIV care continuum outcomes also suggests HRSA wants evaluation designs that connect implementation quality to measurable clinical and engagement outcomes, while producing realistic cost information and operational guidance that Ryan White provider organizations can use.

Is a program contact mentioned for applicant assistance?

Yes. HRSA provided a program contact for applicants needing assistance (the specific contact details are not included in the provided summary).

Browse more opportunities from the same agency: Health Resources and Services Administration

Browse more opportunities from the same category: Health

Next opportunity: DE FOA 0001310 NEXT GENERATION MARINE ENERGY SYSTEMS DURABILITY AND SURVIVABILITY

Previous opportunity: Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Implementation Technical Assistance Center

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for HRSA 15 030

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (HRSA 15 030) also looked into and applied for these:

Funding Opportunity
Analyses of Human Datasets and Biospecimens to Characterize Aging related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01) Apply for RFA AG 16 012

Funding Number: RFA AG 16 012
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
T1 Translational Research Novel Interventions for Prevention and Treatment of Age related Conditions (R21) Apply for PAR 15 190

Funding Number: PAR 15 190
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Consortia for Innovative AIDS Research in Nonhuman Primates (UM1) Apply for RFA AI 15 022

Funding Number: RFA AI 15 022
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 15 195

Funding Number: PAR 15 195
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
T2 Translational Research Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) Apply for PAR 15 191

Funding Number: PAR 15 191
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) Apply for PAR 15 192

Funding Number: PAR 15 192
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) Apply for PAR 15 193

Funding Number: PAR 15 193
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
PPHF 2015 Asian Language Tobacco Quitline financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP15 1503

Funding Number: CDC RFA DP15 1503
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
World Health Organization Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 1505

Funding Number: CDC RFA CK15 1505
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Telehealth Focused Rural Health Research Center Cooperative Agreement Apply for HRSA 15 149

Funding Number: HRSA 15 149
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
NeuroNEXT Small Business Innovation in Clinical Trials Direct to Phase II (U44) Apply for PAR 15 194

Funding Number: PAR 15 194
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Community Sanitation and Nutritional Status in Key Vulnerable Areas in Laos Apply for AID 486 15 000002

Funding Number: AID 486 15 000002
Agency: Thailand USAID Bangkok
Category: Health
Funding Amount: $5,600,000
Developmental AIDS Research Center on Mental Health and HIV/AIDs (P30) Apply for PAR 15 196

Funding Number: PAR 15 196
Agency: National Institutes of Health
Category: Health
Funding Amount: $550,000
AIDS Research Center on Mental Health and HIV/AID (P30) Apply for PAR 15 197

Funding Number: PAR 15 197
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,100,000
Improving Adult Immunization Rates through Partnerships with Providers and National Organizations Apply for CDC RFA IP15 1503

Funding Number: CDC RFA IP15 1503
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
State Falls Prevention Program Supplement Apply for CE11 11010501SUPP15

Funding Number: CE11 11010501SUPP15
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $120,000
Sustainable Condom Solutions Project (SCSP) Apply for RFA 624 15 000003

Funding Number: RFA 624 15 000003
Agency: Ghana USAID Accra
Category: Health
Funding Amount: $4,970,000
Adult Medicaid Quality Improving Maternal and Infant Health Outcomes in Medicaid and CHIP Apply for CMS 1F1 15 001

Funding Number: CMS 1F1 15 001
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $400,000
Health Policy Plus (HP ) Apply for SOL OAA 15 000056

Funding Number: SOL OAA 15 000056
Agency: Agency for International Development
Category: Health
Funding Amount: $185,000,000
Global Health Security Partner Engagement Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 1632

Funding Number: CDC RFA GH15 1632
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "HRSA 15 030", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.